The secretion of IFN-γ was significantly enhanced in H@Gd-NCPs + RT group, and could be further enhanced by synergism with αPD-L1 to achieve optimal tumor immunotherapeutic efficacy (Fig. 7I, j). This evidence concerns the gene IFNG and neoplasm.